Robert R Ruffolo, PhD
Director
Robert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President of R&D and Senior Vice President of Wyeth Pharmaceuticals (now, Pfizer) from 2002 to 2008. Prior to Wyeth, Dr Ruffolo served as Senior Vice President, R&D, at SmithKline Beecham Pharmaceuticals (now, GlaxoSmithKline) for 17 years. He has played a significant role in the discovery and development of a number of successful products, including Carvedilol, Ropinirole, Dobutamine and Eprosartan.
Dr Ruffolo has won several prestigious awards, including the Discoverer’s Award in 2008 for his pioneering work on the discovery of Carvedilol for the treatment of congestive heart failure. He has published over 500 full-length publications, edited 15 books, and was Editor-in-Chief of four international pharmacology journals. Dr Ruffolo was appointed to Aragen’s (formerly, GVK BIO) Board of Directors in April 2019. He was also a Board of Director of Aridis Pharmaceuticals Inc., USA from April 2016 to March 2023.
Professional Experience
- President, R&D and Senior Vice President, Wyeth Pharmaceuticals (now, Pfizer) (2002–2008)
- Senior Vice President, R&D, SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline)
- Chairman, Cardiovascular Research Committee, Eli Lilly and Company
Leadership
- Director, Sapience Therapeutics
- Director, Sigilon Therapeutics
- Director, Elucida Oncology
- Director, X-VAX Technology, Inc
- Director & Chairman, Aragen Bioscience, Inc.
- Director, Elicio Oncology
- President, Ruffolo Consulting LLC (since 2008)
Education
- PhD in Pharmacology, The Ohio State University, USA
- BSc (Summa Cum Laude, and with Distinction) in Pharmacy, The Ohio State University, USA
- Honorary Doctorate in Science (DSc), West Virginia University, USA
- Honorary Doctorate in Engineering (DEng), University of Catania, Italy
Board of Directors
Davinder Singh Brar
ChairmanD S Brar is a life sciences industry veteran, with a career spanning over four decades. Prior to joining Aragen as Promoter-Chairman, Mr Brar led Ranbaxy...
G V Keshav Reddy
DirectorAs a Promoter-Director at Aragen, Keshav Reddy leads board-mandated strategic projects in finance, M&A, branding, structuring and vision planning for...
Rajat Sood
DirectorRajat Sood is a Managing Director in the Asset Management Division at Goldman Sachs, focused on corporate and growth equity investing in India. Mr. Sood...
Dr Amit Varma
DirectorAmit is the Cofounder and Managing Partner of Quadria Capital, Asia’s leading healthcare private equity firm. He has 34 years of experience in investing,...
Robert R Ruffolo, PhD
DirectorRobert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President...
Ajay Srivastava
DirectorAjay Srivastava, has worked with Citibank in the area of Transactional Services and Corporate and Investment Banking for many years. Thereafter, he founded...
Anita Ramachandran
DirectorAnita Ramachandran heads Cerebrus Consultants and is a renowned Human Resource professional with deep knowledge and experience of over 40 years as a management...
Manni Kantipudi
MD & CEOManni Kantipudi joined Aragen in 2007 as President. He is presently MD & CEO and member of the Board of Directors, responsible for the overall growth,...
